Syrbe S et al. De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy. Nat Genet. 2015 Apr;47(4):393-399. PMID: 25751627.
Döring JH et al. Refining Genotypes and Phenotypes in KCNA2-Related Neurological Disorders. Int J Mol Sci. 2021 Mar 10;22(6):2824. PMID: 33802230.
Hedrich UBS et al. 4-Aminopyridine is a promising treatment option for patients with gain-of-function KCNA2-encephalopathy. Sci Transl Med. 2021 Sep;13(609):eaaz4957. PMID: 34516822.
KCNA2